Peers of Lisata Therapeutics Inc (LSTA)
Side-by-side comparison
Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
98.49x
As of Oct 9, 2026
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Oct 9, 2026 | 98.49x |
| Oct 8, 2026 | 109.43x |
| Oct 7, 2026 | 106.69x |
| Oct 6, 2026 | 110.34x |
| Oct 5, 2026 | 114.90x |
| Oct 2, 2026 | 134.05x |
| Oct 1, 2026 | 135.87x |
| Sep 30, 2026 | 131.31x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison